outdated_browser_message

Items Tagged ‘hepatocellular cancer’

February 20, 2018

Cabometyx™ May Be ‘New Treatment Option’ for Liver Cancer

By

CancerConnect News:  Treatment with Cabometyx  (cabozantinib) significantly improved outcomes in patients with advanced hepatocellular carcinoma (HCC), leading researchers to suggest that it could offer a new treatment option for this patient population.  The new findings come from the phase 3 CELESTIAL trial and were presented at the 2018 Gastrointestinal Cancers Symposium.1 About Liver Cancer Liver […]

View full entry

Tags: Cabometyx, cabozantinib, hepatocellular cancer, Liver Cancer, News


February 15, 2018

Keytruda Immunotherapy Appears Active for Treatment of Liver Cancer

By

CancerConnect News:  According to the results of a study presented at the recent gastrointestinal cancer symposia, Keytruda (pembrolizumab) is an active treatment for advanced liver cancer in patients who have already been treated with Nexavar (sorafenib).1 About Liver Cancer Liver cancer, or hepatocellular carcinoma (HCC), is the second most common cause of cancer-related deaths worldwide.2,3 […]

View full entry

Tags: checkpoint inhibitor, hepatocellular cancer, immunotherapy, keytruda, Liver Cancer, News, pembrolizumab, Precision Cancer Medicine